Evidence map›Paper›PMID 29997143›Full record

Observational studyBMJ open2018

Evaluation of patient-reported outcome measurements as a reliable tool to measure acceptability of the taste of paediatric medicines in an inpatient paediatric population.

Punam Mistry, Heather Stirling, Claire Callens, James Hodson, Hannah Batchelor, SPaeDD-UK project

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07424495 (Chewable Tablets Produced by Three-Dimensional Printing), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07424495 not yet recruitingnot on this mapstarted 2027, after this paper: background citation

Chewable Tablets Produced by Three-Dimensional Printing: A Sensory Acceptability Study in Children and Adolescents

Typeobservational_patient_registrySponsorUniversity of BrasiliaRan2027 to 2028Enrolled100ConditionsPalatability Assessment of 3D-printed Chewable Tablets in Children and Adolescents
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Punam MistrySchool of Pharmacy, Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.
Heather StirlingPaediatrics, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
Claire CallensNIHR Clinical Research Network West Midlands, Institute of Research and Development, Birmingham, UK.
James HodsonInstitute of Translational Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
Hannah BatchelorSchool of Pharmacy, Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.ORCID 0000-0002-8729-9951
SPaeDD-UK project

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the age appropriateness and suitability of patient-reported outcome measures to assess the acceptability of the taste of oral liquid medicines in children. DESIGN AND

settingAn observational mixed-methods study involving children aged 2-16 years taking oral liquid medicine in paediatric inpatient wards across the West Midlands (UK). Assessment tools included patient-reported scores on the taste of medicines via a five-point Facial Hedonic Scale; a Visual Analogue Scale (VAS); a question, 'Did you think the medicine tasted OK?' and researcher observations of facial expressions and behaviours immediately before, during and after administration.

results611 children participated. The percent unable to complete the scales was 7% (n=46) for the VAS; 2% (n=15) for the hedonic scale and 1% (n=7) for the question about taste. Significant correlations (Spearman's r) were observed between the patient-reported outcome measures: 0.80 and 0.78 for the taste question and hedonic and VAS, respectively, and 0.84 for the hedonic and VAS. Researcher observations demonstrated the ability of the patient to take the medicine as intended but did not provide sensitive measures of taste. 5% of administrations were not taken as intended by the children. Medicines known to have poor taste (clarithromycin and prednisolone) showed mean hedonic and VAS scores of ≥3.5 and >65 mm, respectively.

conclusionsPatient-reported outcome measures correlate with each other and are a useful means to assess the taste (and acceptability) of medicines. Hedonic scales are better understood by children and should be the first choice tool in the assessment of medicines taste.

Indexed as

Child, HospitalizedAdministration, OralAdolescentChildChild, PreschoolDrug EvaluationFacial ExpressionFemaleHealth Services ResearchHumansMalePatient PreferencePatient Reported Outcome MeasuresPharmaceutical PreparationsReproducibility of ResultsSuspensionsPharmaceutical PreparationsSuspensionsacceptabilityage-appropriatehedonic scalemedicinespaediatric medicinepatient-reported outcome measurestasteVAS

Identifiers

PMID29997143
PMCPMC6082459

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.